Camlin Fine Sciences Limited announced that its senior management team will engage in a conference call with investors and analysts on Friday, February 13, 2026. The call is scheduled to discuss the un-audited financial results for the quarter and nine months ended December 31, 2025. The company has provided details for the conference call, including pre-registration links and access numbers for various regions. The call will feature Mr. Ashish Dandekar (Chairman & Managing Director), Mr. Nirmal Momaya (Managing Director), and Mr. Santosh Parab (Chief Financial Officer). Discussions will be based on publicly available information, and no unpublished price-sensitive information (UPSI) is intended to be discussed. The company noted that the date of the scheduled call is subject to change due to exigencies.
